Gastric Cancer Tumouroids (No. 2)
Source 10.7150/ijbs.10248
Abstract
This protocol describes the isolation of primary gastric cancer cells from patient tumour tissue via enzymatic digestion and mechanical dissection, followed by organoid culture in a defined medium supplemented with growth factors and ROCK inhibitor. Cultured organoids are exposed to chemotherapeutic agents (5-FU, oxaliplatin, irinotecan, epirubicin, docetaxel) and targeted therapeutics (trastuzumab, palbociclib, imatinib) to assess drug responses and establish patient-specific sensitivity profiles for gastric cancer.
Protocol overview
18 steps across 7 phases
- a Tissue cutting and washing
- b Enzymatic digestion of tumour tissue
- c Tumour patch isolation
- d Centrifugation of tumour patches
- a Resuspension in Matrigel
- b Overlay with culture medium and ROCK inhibitor
- a Culture medium composition
- a Organoid seeding into multiwell plates
- b Treatment with chemotherapeutic agents (5-FU, oxaliplatin, irinotecan, epirubicin, docetaxel)
- c Treatment with targeted therapeutics
- a Presto Blue cell viability assay
- b Apoptosis assay by flow cytometry
- c EdU proliferation assay
- a Organoid fixation and embedding
- b Immunohistochemical staining
- c Imaging
- a Protein extraction and quantification
- b Western blot antibody incubation
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol